HPV Roundtable, BToush 10/11/ 17 HPV Roundtable, Stroup 10/11/17 HPV Roundtable,Tsui 10/11/17
In this New York Times OP-ED, Paul A. Offit , professor of pediatrics in the division of infectious diseases, and director of the Vaccine Education Center, at the Children’s Hospital of Philadelphia talks about the importance of HPV vaccine in preventing cancer in our children. The New York Times
Make sure your preteen and teen get the meningococcal conjugate vaccine for protection against meningococcal disease, a very serious illness where death can occur in as little as a few hours. The meningococcal conjugate vaccine is recommended at 11–12 years of age and a booster dose at age 16. http://www.cdc.gov/features/meningococcal/
Human Papillomavirus Vaccination Coverage Among Adolescent Girls, 2007–2012, and Postlicensure Vaccine Safety Monitoring, 2006–2013 — United States
Since mid-2006, the Advisory Committee on Immunization Practices (ACIP) has recommended routine vaccination of adolescent girls at ages 11 or 12 years with 3 doses of human papillomavirus (HPV) vaccine (1). Two HPV vaccines are currently available in the United States.